Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C160545> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- NCIT_C160545 IAO_0000115 "A regimen consisting of bortezomib, dexamethasone, and rituximab that may be used in the treatment of Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma, Castleman disease, and mantle cell lymphoma." @default.
- NCIT_C160545 NCIT_NHC0 "C160545" @default.
- NCIT_C160545 NCIT_P106 "Therapeutic or Preventive Procedure" @default.
- NCIT_C160545 NCIT_P108 "BDR Regimen" @default.
- NCIT_C160545 NCIT_P208 "CL969473" @default.
- NCIT_C160545 NCIT_R123 NCIT_C129821 @default.
- NCIT_C160545 NCIT_R123 NCIT_C129822 @default.
- NCIT_C160545 NCIT_R123 NCIT_C1362 @default.
- NCIT_C160545 NCIT_R123 NCIT_C141215 @default.
- NCIT_C160545 NCIT_R123 NCIT_C147908 @default.
- NCIT_C160545 NCIT_R123 NCIT_C1636 @default.
- NCIT_C160545 NCIT_R123 NCIT_C163758 @default.
- NCIT_C160545 NCIT_R123 NCIT_C164034 @default.
- NCIT_C160545 NCIT_R123 NCIT_C1702 @default.
- NCIT_C160545 NCIT_R123 NCIT_C1851 @default.
- NCIT_C160545 NCIT_R123 NCIT_C1908 @default.
- NCIT_C160545 NCIT_R123 NCIT_C1909 @default.
- NCIT_C160545 NCIT_R123 NCIT_C20401 @default.
- NCIT_C160545 NCIT_R123 NCIT_C211 @default.
- NCIT_C160545 NCIT_R123 NCIT_C2160 @default.
- NCIT_C160545 NCIT_R123 NCIT_C2364 @default.
- NCIT_C160545 NCIT_R123 NCIT_C274 @default.
- NCIT_C160545 NCIT_R123 NCIT_C307 @default.
- NCIT_C160545 NCIT_R123 NCIT_C308 @default.
- NCIT_C160545 NCIT_R123 NCIT_C471 @default.
- NCIT_C160545 NCIT_R123 NCIT_C521 @default.
- NCIT_C160545 NCIT_R123 NCIT_C548 @default.
- NCIT_C160545 NCIT_R123 NCIT_C574 @default.
- NCIT_C160545 normalizedInformationContent "100" @default.
- NCIT_C160545 referenceCount "1" @default.
- NCIT_C160545 hasExactSynonym "BDR Regimen" @default.
- NCIT_C160545 hasExactSynonym "BDR" @default.
- NCIT_C160545 hasExactSynonym "BORID" @default.
- NCIT_C160545 hasExactSynonym "Bortezomib-Dexamethasone-Rituximab" @default.
- NCIT_C160545 hasExactSynonym "Bortezomib/Dexamethasone + Rituximab" @default.
- NCIT_C160545 hasExactSynonym "Bortezomib/Dexamethasone Plus Rituximab" @default.
- NCIT_C160545 hasExactSynonym "Bortezomib/Dexamethasone/Rituximab Regimen" @default.
- NCIT_C160545 hasExactSynonym "Bortezomib/Dexamethasone/Rituximab" @default.
- NCIT_C160545 hasExactSynonym "Velcade/Decadron/Rituxan" @default.
- NCIT_C160545 inSubset NCIT_C160950 @default.
- NCIT_C160545 inSubset NCIT_C160952 @default.
- NCIT_C160545 type Class @default.
- NCIT_C160545 isDefinedBy ncit.owl @default.
- NCIT_C160545 label "BDR Regimen" @default.
- NCIT_C160545 subClassOf B500942aa1601a71d9aac4b7757c69af6 @default.
- NCIT_C160545 subClassOf B757c4fcf23b10c27745f242a1fe0d74d @default.
- NCIT_C160545 subClassOf Bb541dbb7d7a420790f8aacdc97378ae2 @default.
- NCIT_C160545 subClassOf Bbdb69f6f98c63c4843d25c476196e65d @default.
- NCIT_C160545 subClassOf Bc95c97ff5edd133dfdd6580d3ee5a401 @default.
- NCIT_C160545 subClassOf Bdd833318e144d67748c303721c51dee8 @default.
- NCIT_C160545 subClassOf NCIT_C12218 @default.
- NCIT_C160545 subClassOf NCIT_C160545 @default.
- NCIT_C160545 subClassOf NCIT_C186719 @default.
- NCIT_C160545 subClassOf NCIT_C186724 @default.
- NCIT_C160545 subClassOf NCIT_C191723 @default.
- NCIT_C160545 subClassOf NCIT_C191727 @default.
- NCIT_C160545 subClassOf NCIT_C62634 @default.
- NCIT_C160545 subClassOf NCIT_C63442 @default.